Literature DB >> 11684567

Rhabdomyolysis, acute renal failure, and death after monensin ingestion.

C Caldeira1, W S Neves, P M Cury, P Serrano, M A Baptista, E A Burdmann.   

Abstract

We report a case of human monensin intoxication; to our knowledge, this is the first reported case in the medical literature. The patient took a dose of monensin three times higher than a dose considered lethal for cattle and developed a clinical picture similar to that reported in veterinary medicine. There was an early and extremely severe rhabdomyolysis followed by acute renal failure, heart failure, and death. The main changes observed at autopsy were extensive skeletal muscle necrosis, complement deposition at the myocardial level, pulmonary edema, and acute tubular damage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684567     DOI: 10.1053/ajkd.2001.28618

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

1.  New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.

Authors:  Lucie Fénéant; Julie Potel; Catherine François; Famara Sané; Florian Douam; Sandrine Belouzard; Noémie Calland; Thibaut Vausselin; Yves Rouillé; Véronique Descamps; Thomas F Baumert; Gilles Duverlie; Dimitri Lavillette; Didier Hober; Jean Dubuisson; Czeslaw Wychowski; Laurence Cocquerel
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

2.  Genomics-driven discovery of the biosynthetic gene cluster of maduramicin and its overproduction in Actinomadura sp. J1-007.

Authors:  Ran Liu; Fang Fang; Ziheng An; Renqiong Huang; Yong Wang; Xiao Sun; Shuai Fu; Aisi Fu; Zixin Deng; Tiangang Liu
Journal:  J Ind Microbiol Biotechnol       Date:  2019-12-18       Impact factor: 3.346

Review 3.  Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components.

Authors:  Alison E Barnhill; Matt T Brewer; Steve A Carlson
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

4.  Selenium inhibits renal oxidation and inflammation but not acute kidney injury in an animal model of rhabdomyolysis.

Authors:  Anu Shanu; Ludwig Groebler; Hyun Bo Kim; Sarah Wood; Claire M Weekley; Jade B Aitken; Hugh H Harris; Paul K Witting
Journal:  Antioxid Redox Signal       Date:  2012-10-16       Impact factor: 8.401

5.  Biodistribution of diphenhydramine in reproductive organs in an overdose case.

Authors:  Shigeki Oritani; Tomomi Michiue; Jian-Hua Chen; Naoto Tani; Takaki Ishikawa
Journal:  Hum Cell       Date:  2016-11-12       Impact factor: 4.174

6.  Survival After Severe Rhabdomyolysis Following Monensin Ingestion.

Authors:  Michela Blain; Alexander Garrard; Robert Poppenga; Betty Chen; Matthew Valento; Melissa Halliday Gittinger
Journal:  J Med Toxicol       Date:  2017-05-17

7.  Salinomycin, a polyether ionophoric antibiotic, inhibits adipogenesis.

Authors:  Maria Szkudlarek-Mikho; Rudel A Saunders; Sook Fan Yap; Yun Fong Ngeow; Khew-Voon Chin
Journal:  Biochem Biophys Res Commun       Date:  2012-10-31       Impact factor: 3.575

8.  P-glycoprotein limits oral availability, brain penetration, and toxicity of an anionic drug, the antibiotic salinomycin.

Authors:  Jurjen S Lagas; Rolf W Sparidans; Robert A B van Waterschoot; Els Wagenaar; Jos H Beijnen; Alfred H Schinkel
Journal:  Antimicrob Agents Chemother       Date:  2008-01-14       Impact factor: 5.191

9.  Jacobsen catalyst as a cytochrome P450 biomimetic model for the metabolism of monensin A.

Authors:  Bruno Alves Rocha; Anderson Rodrigo Moraes de Oliveira; Murilo Pazin; Daniel Junqueira Dorta; Andresa Piacezzi Nascimento Rodrigues; Andresa Aparecida Berretta; Ana Paula Ferranti Peti; Luiz Alberto Beraldo de Moraes; Norberto Peporine Lopes; Stanislav Pospíšil; Paul Jonathan Gates; Marilda das Dores Assis
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

10.  Chronic exposure of low dose salinomycin inhibits MSC migration capability in vitro.

Authors:  Agmal Scherzad; Stephan Hackenberg; Katrin Froelich; Kristen Rak; Rudolf Hagen; Johannes Taeger; Maximillian Bregenzer; Norbert Kleinsasser
Journal:  Biomed Rep       Date:  2016-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.